Publicaciones en colaboración con investigadores/as de Instituto Cajal (25)

2021

  1. Amino-Cupric-Silver (A-Cu-Ag) Staining to Detect Neuronal Degeneration in the Mouse Brain: The de Olmos Technique

    Neuromethods (Humana Press Inc.), pp. 3-19

  2. Behavioral sensitization and cellular responses to psychostimulants are reduced in D2R knockout mice

    Addiction Biology, Vol. 26, Núm. 1

  3. Genetic deletion of dopamine D1 receptors increases the sensitivity to cannabinoid CB1 receptor antagonist-precipitated withdrawal when compared with wild-type littermates: studies in female mice repeatedly exposed to the Spice cannabinoid HU-210

    Psychopharmacology, Vol. 238, Núm. 2, pp. 551-557

2020

  1. Modeling Parkinson’s Disease With the Alpha-Synuclein Protein

    Frontiers in Pharmacology, Vol. 11

2018

  1. Striatal Reinnervation Process after Acute Methamphetamine-Induced Dopaminergic Degeneration in Mice

    Neurotoxicity Research, Vol. 34, Núm. 3, pp. 627-639

2017

  1. Amphetamine-related drugs neurotoxicity in humans and in experimental animals: Main mechanisms

    Progress in Neurobiology, Vol. 155, pp. 149-170

2016

  1. Fragment C domain of tetanus toxin mitigates methamphetamine neurotoxicity and its motor consequences in mice

    International Journal of Neuropsychopharmacology, Vol. 19, Núm. 8, pp. 1-11

2015

  1. Methamphetamine-Induced Toxicity in Indusium Griseum of Mice is Associated with Astro- and Microgliosis

    Neurotoxicity Research, Vol. 27, Núm. 3, pp. 209-216

2014

  1. Aging-related dysregulation of dopamine and angiotensin receptor interaction

    Neurobiology of Aging, Vol. 35, Núm. 7, pp. 1726-1738

  2. D1 but not D4 dopamine receptors are critical for MDMA-induced neurotoxicity in mice

    Neurotoxicity Research, Vol. 25, Núm. 1, pp. 100-109

  3. Methamphetamine causes degeneration of dopamine cell bodies and terminals of the nigrostriatal pathway evidenced by silver staining

    Neuropsychopharmacology, Vol. 39, Núm. 5, pp. 1066-1080

  4. The JNK inhibitor, SP600125, potentiates the glial response and cell death induced by methamphetamine in the mouse striatum

    International Journal of Neuropsychopharmacology, Vol. 17, Núm. 2, pp. 235-246

2013

  1. Cocaine potentiates MDMA-induced oxidative stress but not dopaminergic neurotoxicity in mice: Implications for the pathogenesis of free radical-induced neurodegenerative disorders

    Psychopharmacology, Vol. 230, Núm. 1, pp. 125-135

  2. Methamphetamine and parkinson's disease

    Parkinson's Disease

  3. The role of dopamine receptors in the neurotoxicity of methamphetamine

    Journal of Internal Medicine, Vol. 273, Núm. 5, pp. 437-453

2012

  1. Dopamine D 1 receptor deletion strongly reduces neurotoxic effects of methamphetamine

    Neurobiology of Disease, Vol. 45, Núm. 2, pp. 810-820

2011

  1. Dopamine D2-receptor knockout mice are protected against dopaminergic neurotoxicity induced by methamphetamine or MDMA

    Neurobiology of Disease, Vol. 42, Núm. 3, pp. 391-403

  2. Nrf2 deficiency potentiates methamphetamine-induced dopaminergic axonal damage and gliosis in the striatum

    GLIA, Vol. 59, Núm. 12, pp. 1850-1863

2010

  1. Genetic inactivation of Pleiotrophin triggers amphetamine-induced cell loss in the substantia nigra and enhances amphetamine neurotoxicity in the striatum

    Neuroscience, Vol. 170, Núm. 1, pp. 308-316

  2. Selective vulnerability in striosomes and in the nigrostriatal dopaminergic pathway after methamphetamine administration : early loss of TH in striosomes after methamphetamine.

    Neurotoxicity research, Vol. 18, Núm. 1, pp. 48-58